Virtual Posters: Health-Related Quality of Life in Ovarian Cancer: methodological issues in Randomised Controlled Trials

Virtual Posters

Conclusions

Lack of clear reporting of trial withdrawals and inappropriate statistical methods for handling missing data and informative censoring are predominant in the ovarian cancer trial literature. This may bias results and limit information in understanding disease impact and any therapeutic treatment benefits. Future trials should focus on these methodological limitations and a priori definitions of minimally important differences in HRQOL outcomes.